Zobrazeno 1 - 10
of 50
pro vyhledávání: '"M Contente"'
Autor:
Prianka Singh, Jennifer P Hall, A. Bailey, Hollie Bailey, M. Contente, Bryan Bennett, Carlos Polanco Sanchez, Luigi Zarrelli
Publikováno v:
Advances in Therapy. 38:4722-4735
Squamous cell carcinomas of the head and neck (SCCHN) account for approximately 4% of all malignancies and are associated with high morbidity and poor prognosis. For patients who are not eligible for surgery or radiotherapy, treatment options are lim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a86e121f94df91ac65444250fe41610
https://doi.org/10.1007/s12325-021-01851-2
https://doi.org/10.1007/s12325-021-01851-2
Publikováno v:
Value in Health. 25:S374
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0d35d2bfaf53f9cd85d29b66fd7faaa2
https://doi.org/10.1016/j.jval.2022.09.1856
https://doi.org/10.1016/j.jval.2022.09.1856
Publikováno v:
Value in Health. 25:S368
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5fbac86218fe022e2a6b7fc2da38c554
https://doi.org/10.1016/j.jval.2022.09.1828
https://doi.org/10.1016/j.jval.2022.09.1828
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Prianka Singh, Chris Curtis, Tom Bailey, Gavin Taylor-Stokes, Ivana Rajkovic, Bryan Bennett, M. Contente, Sharon Curtis
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-12 (2021)
BMC Cancer
BMC Cancer
Background Although current therapy for patients with early-stage squamous cell carcinoma of the head and neck (SCCHN) is potentially curative, the recurrence rate is high. Patients with recurrent or metastatic (R/M) SCCHN have a poor prognosis and s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea64b27b0b49eac99daa0caa5cc08072
https://doi.org/10.1186/s12885-021-08557-2
https://doi.org/10.1186/s12885-021-08557-2
Publikováno v:
Pharmacoeconomics
Objectives In the CheckMate 141 trial (NCT02105636), nivolumab demonstrated survival, health-related quality of life, and healthcare resource utilization benefits vs single-agent therapy of investigator’s choice (IC) (methotrexate, docetaxel or cet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76deb6c81defba2d2605d539f7b8c46c
https://doi.org/10.1007/s40273-019-00798-1
https://doi.org/10.1007/s40273-019-00798-1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Cynthia Macahilig, Alicia C. Shillington, Christopher Kiff, FE Cotte, V Dave, P Singh, M Contente
Publikováno v:
Value in Health. 23:S427
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e8778a73ee8bdb30165ca8462863444
https://doi.org/10.1016/j.jval.2020.08.172
https://doi.org/10.1016/j.jval.2020.08.172
Publikováno v:
Value in Health. 22:S804-S805
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::97adafb9c18cc5e0444893c2e6165c34
https://doi.org/10.1016/j.jval.2019.09.2154
https://doi.org/10.1016/j.jval.2019.09.2154
Autor:
C. Polanco, A. Bailey, M. Contente, J. Hall, M. Mtibaa, Prianka Singh, P. Di Rienzo, H. Bailey
Publikováno v:
Value in Health. 22:S108-S109
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::14546fee22471c676b670c0ecc25fee6
https://doi.org/10.1016/j.jval.2019.04.397
https://doi.org/10.1016/j.jval.2019.04.397